Breast cancer research explores metabolic pathways and metal-based treatments

Recent academic research has focused on identifying new metabolic and chemical pathways to combat breast cancer, particularly in cases involving metastasis and triple-negative subtypes.

At the University of Ottawa, researchers investigated the role of PGC-1α in breast cancer liver metastasis. The study found that liver-tropic breast cancer cells typically exhibit low expression of PGC-1α, a regulator of mitochondrial biogenesis, and instead rely on a glycolytic metabolic program. The research utilized a dual-compartment experimental strategy to examine how PGC-1α overexpression affects mitochondrial ATP production and metastatic fitness.

In a separate study, researchers evaluated the efficacy of various metal-based complexes, including copper and gold, against triple-negative breast cancer (TNBC) cell lines. Because TNBC lacks receptors for estrogen, progesterone, and HER2, targeted therapies are often ineffective. The study tested a library of phenanthroline- and theophylline-based copper complexes and gold(I) complexes to determine their ability to induce apoptotic cell death and influence mitochondrial function.